 |
|
Intraviteal Bevacizumab (Avastin(R)) Injection for the Treatment of Early-Stage Neovascular Glaucoma.
Hyosung Maeng, Jinchul Kim, Changwon Kee
J Korean Ophthalmol Soc. 2008;49(4):696-700. Published online 2008 Apr 15 DOI: https://doi.org/10.3341/jkos.2008.49.4.696
|
|
Citations to this article as recorded by
 Effect of Simultaneous Intravitreal Bevacizumab and Retrobulbar Triamcinolone Injection in Refractory Neovascular Glaucoma
Woo-Jin Kim, Jin-Gu Jeong, In-Cheon You, Dong-Wook Lee
Journal of the Korean Ophthalmological Society.2010; 51(4): 568. CrossRef Concentration of Vascular Endothelial Growth Factor After Intracameral Bevacizumab Injection in Eyes With Neovascular Glaucoma
Tae Hoon Lim, Soong Hwan Bae, Young Jae Cho, Jun Haeng Lee, Hwang Ki Kim, Yong Ho Sohn
Korean Journal of Ophthalmology.2009; 23(3): 188. CrossRef Intravitreal Bevacizumab for the Treatment of Neovascular Glaucoma Associated With Central Retinal Artery Occlusion
Min Sagong, Jinseon Kim, Woohyok Chang
Korean Journal of Ophthalmology.2009; 23(3): 215. CrossRef Intravitreal Bevacizumab Injection as Preoperative Adjuvant of Vitrectomy for Proliferative Diabetic Retinopathy
Min Kyu Shin, Na Mi Kim, Ji Eun Lee, Boo Sup Oum
Journal of the Korean Ophthalmological Society.2009; 50(5): 731. CrossRef
|